Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Recruiting × Malignant Ascites × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 143 Neoplasms 130 Neoplasm Metastasis 126 Leukemia, Myeloid, Acute 126 Breast Neoplasms 121 Colorectal Neoplasms 113 Recurrence 91 Ovarian Neoplasms 89 Pancreatic Neoplasms 74 Advanced Solid Tumor 72 Prostatic Neoplasms 65 Multiple Myeloma 63 Lung Neoplasms 63 Advanced Solid Tumors 59 Stomach Neoplasms 58 Squamous Cell Carcinoma of Head and Neck 58 Lymphoma, Non-Hodgkin 57 Triple Negative Breast Neoplasms 55 Melanoma 52 Carcinoma, Hepatocellular 52 Glioblastoma 51 Precursor Cell Lymphoblastic Leukemia-Lymphoma 49 Lymphoma 49 Lymphoma, B-Cell 47 Myelodysplastic Syndromes 46 Endometrial Neoplasms 46 Glioma 43 Hematologic Neoplasms 40 Lymphoma, Large B-Cell, Diffuse 39 Carcinoma, Renal Cell 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07007988 2025-06-06

SIM0388-101

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 1 Recruiting

Malignant Ascites

Data powered by HemOnc (CC BY 4.0) Colophon ⚡